Hyperblebbing Shigella strains

Details for Australian Patent Application No. 2010299577 (hide)

Owner Novartis Vaccines Institute for Global Health SRL

Inventors Gerke, Christiane; Berlanda Scorza, Francesco; Saul, Allan; Maggiore, Luana

Agent FB Rice

Pub. Number AU-A-2010299577

PCT Pub. Number WO2011/036564

Priority 0917002.8 28.09.09 GB

Filing date 28 September 2010

Wipo publication date 31 March 2011

International Classifications

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

C07K 14/25 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 9/12 (2006.01) Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/036564 Priority application(s): WO2011/036564

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010299579-Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

2010299574-Process